Reaction
Magnetic Resonance Imaging Head Abnormal reporting signals
As of the last recalculation, Magnetic Resonance Imaging Head Abnormal appears in 637 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is VIGABATRIN (PRR 648.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Vigabatrin | 199 | 648.3 | 657.3 |
| Ocrelizumab | 88 | 53.6 | 53.7 |
| Phenobarbital | 21 | 48.9 | 49.0 |
| Ozanimod Hydrochloride | 10 | 40.0 | 40.0 |
| Zonisamide | 12 | 27.0 | 27.0 |
| Brimonidine Tartrate | 14 | 26.2 | 26.3 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 5 | 16.4 | 16.4 |
| Clobazam | 12 | 16.4 | 16.4 |
| Levetiracetam In Sodium Chloride | 36 | 16.0 | 16.0 |
| Levetiracetam Oral | 36 | 16.0 | 16.0 |
| Levetiracetam Injection | 36 | 16.0 | 16.0 |
| Vemurafenib | 4 | 10.9 | 10.9 |
| Avapritinib | 4 | 10.9 | 10.9 |